Literature DB >> 23975366

Association between GSTP1 Ile105Val polymorphism and glioma risk: a systematic review and meta-analysis.

Peng Xie1, Yong Liang, Guobiao Liang, Bing Liu.   

Abstract

Glutathione S-transferase P1 (GSTP1) gene Ile105Val polymorphism has been suggested to be involved in the development of glioma. However, the results from the studies regarding the association between GSTP1 Ile105Val polymorphism and glioma risk have been inconsistent. Thus, we performed a meta-analysis to investigate this association. Pooled odds ratios (ORs) with 95% confidence intervals (95%CIs) were calculated using random or fixed effects model. Nine studies with 2,078 cases and 3,970 controls were finally included into this meta-analysis. The results suggested there was no association between GSTP1 Ile105Val polymorphism and glioma risk under recessive model (OR = 1.138, 95%CI = 0.966-1.341, Pheterogeneity = 0.088, P = 0.123). Subgroup analyses by ethnicity showed there was also no association between GSTP1 Ile105Val polymorphism and glioma risk in mixed populations under recessive model (OR = 1.199, 95%CI = 0.928-1.549, Pheterogeneity = 0.060, P = 0.166) and Caucasian populations (OR = 1.097, 95%CI = 0.885-1.360, Pheterogeneity = 0.186, P = 0.398). In conclusion, the meta-analysis suggests that there is no association between GSTP1 Ile105Val polymorphism and glioma risk. However, more well-designed and larger studies are needed to further assess this association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975366     DOI: 10.1007/s13277-013-1069-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  28 in total

Review 1.  An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review.

Authors:  Zengnan Mo; Yong Gao; Yunfei Cao; Feng Gao; Lijuan Jian
Journal:  Prostate       Date:  2009-05-01       Impact factor: 4.104

Review 2.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 4.  Genetic advances in glioma: susceptibility genes and networks.

Authors:  Yanhong Liu; Sanjay Shete; Fay Hosking; Lindsay Robertson; Richard Houlston; Melissa Bondy
Journal:  Curr Opin Genet Dev       Date:  2010-03-06       Impact factor: 5.578

Review 5.  The glutathione S-transferases: influence of polymorphism on cancer susceptibility.

Authors:  R C Strange; A A Fryer
Journal:  IARC Sci Publ       Date:  1999

6.  Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk: a meta-analysis.

Authors:  Konstantinos P Economopoulos; Theodoros N Sergentanis; Nikos F Vlahos
Journal:  Int J Gynecol Cancer       Date:  2010-07       Impact factor: 3.437

7.  Genetic polymorphisms of GSTs and their association with primary brain tumor incidence.

Authors:  Hatice Pinarbasi; Yavuz Silig; Mustafa Gurelik
Journal:  Cancer Genet Cytogenet       Date:  2005-01-15

8.  Genome-wide association study identifies five susceptibility loci for glioma.

Authors:  Sanjay Shete; Fay J Hosking; Lindsay B Robertson; Sara E Dobbins; Marc Sanson; Beatrice Malmer; Matthias Simon; Yannick Marie; Blandine Boisselier; Jean-Yves Delattre; Khe Hoang-Xuan; Soufiane El Hallani; Ahmed Idbaih; Diana Zelenika; Ulrika Andersson; Roger Henriksson; A Tommy Bergenheim; Maria Feychting; Stefan Lönn; Anders Ahlbom; Johannes Schramm; Michael Linnebank; Kari Hemminki; Rajiv Kumar; Sarah J Hepworth; Amy Price; Georgina Armstrong; Yanhong Liu; Xiangjun Gu; Robert Yu; Ching Lau; Minouk Schoemaker; Kenneth Muir; Anthony Swerdlow; Mark Lathrop; Melissa Bondy; Richard S Houlston
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

9.  Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

Authors:  Margaret Wrensch; Robert B Jenkins; Jeffrey S Chang; Ru-Fang Yeh; Yuanyuan Xiao; Paul A Decker; Karla V Ballman; Mitchel Berger; Jan C Buckner; Susan Chang; Caterina Giannini; Chandralekha Halder; Thomas M Kollmeyer; Matthew L Kosel; Daniel H LaChance; Lucie McCoy; Brian P O'Neill; Joe Patoka; Alexander R Pico; Michael Prados; Charles Quesenberry; Terri Rice; Amanda L Rynearson; Ivan Smirnov; Tarik Tihan; Joe Wiemels; Ping Yang; John K Wiencke
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

Review 10.  Cancer drugs, genetic variation and the glutathione-S-transferase gene family.

Authors:  Danyelle Townsend; Kenneth Tew
Journal:  Am J Pharmacogenomics       Date:  2003
View more
  6 in total

1.  Genetic Contribution of Polymorphisms in Glutathione S-Transferases to Brain Tumor Risk.

Authors:  Peiliang Geng; Jianjun Li; Ning Wang; Juanjuan Ou; Ganfeng Xie; Rina Sa; Chen Liu; Lisha Xiang; Hongtao Li; Houjie Liang
Journal:  Mol Neurobiol       Date:  2015-03-04       Impact factor: 5.590

2.  Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia.

Authors:  Ju Bai; Aili He; Chen Huang; Juan Yang; Wanggang Zhang; Jianli Wang; Yun Yang; Pengyu Zhang; Yang Zhang; Fuling Zhou
Journal:  Proteome Sci       Date:  2014-09-16       Impact factor: 2.480

3.  Comprehensive Analysis of the Association Between the rs1138272 Polymorphism of the GSTP1 Gene and Cancer Susceptibility.

Authors:  Fei Ding; Jin-Ping Li; Yong Zhang; Guang-Hui Qi; Zhi-Chao Song; Yong-Hua Yu
Journal:  Front Physiol       Date:  2019-01-25       Impact factor: 4.566

4.  Association of the VEGFR2 single nucleotide polymorphism rs2305948 with glioma risk.

Authors:  Shushu Sun; Xiaotian Li; Bingkun Qu; Kunming Xie; Jinlei Li; Junjie Miao
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

5.  GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk.

Authors:  Veljko Santric; Milica Djokic; Sonja Suvakov; Marija Pljesa-Ercegovac; Marina Nikitovic; Tanja Radic; Miodrag Acimovic; Vesna Stankovic; Uros Bumbasirevic; Bogomir Milojevic; Uros Babic; Zoran Dzamic; Tatjana Simic; Dejan Dragicevic; Ana Savic-Radojevic
Journal:  Medicina (Kaunas)       Date:  2020-03-13       Impact factor: 2.430

6.  Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma.

Authors:  Kecheng Lei; Xiaoxia Gu; Alvaro G Alvarado; Yuhong Du; Shilin Luo; Eun Hee Ahn; Seong Su Kang; Bing Ji; Xia Liu; Hui Mao; Haian Fu; Harley I Kornblum; Lingjing Jin; Hua Li; Keqiang Ye
Journal:  J Hematol Oncol       Date:  2020-10-21       Impact factor: 23.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.